Quote:
Originally Posted by Halfcan
IBIO is listed on the NYSE - not the OTC boards.
iBio, Inc. (NYSE MKT: IBIO), a leader in the plant-made pharmaceutical field, develops and offers pharmaceutical product applications using its iBio Technology platform.
The iBio Technology platform is a proprietary, transformative technology for the production of biologics including monoclonal antibodies, other therapeutic proteins and vaccines.
|
Sure. But it’s been trading below $1 for a long time.